Last reviewed · How we verify

NCT06756178

Effect of Remimazolam Versus Dexmedetomidine on the Incidence of Delirium After Elective Cardiac Surgery with Cardiopulmonary Bypass: a Prospective Randomized Controlled Trial

Not yet recruiting EARLY_PHASE1 Last updated 1 January 2025
What this trial tests

EARLY_PHASE1 trial testing Propofol Group 1 in Delirium - Postoperative in 111 participants. Not yet recruiting.

Timeline
10 January 2025
Primary endpoint
1 November 2026
1 November 2027

Quick facts

Lead sponsorAssiut University
PhaseEARLY_PHASE1
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment111
Start date10 January 2025
Primary completion1 November 2026
Estimated completion1 November 2027
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

18 and older, any sex, with Delirium - Postoperative. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to improve the post-open heart surgery lifestyle and overall experience, as well as assess the incidence of delirium using Remimazolam and Dexmedetomidine.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Propofol Group 1

Trials testing the same drug.

Other recruiting trials for Delirium - Postoperative

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06756178.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing